Working paper icon

Working paper

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study

Abstract:

Background: Hydroxychloroquine has recently received Emergency Use Authorization by the FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. We studied the safety of hydroxychloroquine, alone and in combination with azithromycin.

Methods: New user cohort studies were conducted including 16 severe adverse events (SAEs). Rheumatoid arthritis patients aged 18+ and initiating hydroxychloroquine were compared to thos...

Expand abstract
Publication status:
Not published
Peer review status:
Not peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1101/2020.04.08.20054551

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Botnar Research Centre
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author, Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author, Author
Expand authors...

Contributors

Role:
Contributor
et al.
Publisher:
Cold Spring Harbor Laboratory Press Publisher's website
Journal:
medRxiv
Publication date:
2020-05-31
DOI:
Language:
English
Keywords:
Pubs id:
1100093
Local pid:
pubs:1100093
Deposit date:
2020-04-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP